The role of Herceptin in early breast cancer

Autor:	Kefah Mokbel, Ashok Subramanian
Jazyk:	angličtina
Předmět:	Gynecology Oncology medicine.medical_specialty business.industry Review medicine.disease Multidisciplinary team Breast cancer Surgical oncology Internal medicine medicine Surgery business skin and connective tissue diseases Tamoxifen medicine.drug Early breast cancer
Zdroj:	International seminars in surgical oncology : ISSO
ISSN:	1477-7800
DOI:	10.1186/1477-7800-5-9
Popis:	Herceptin is widely regarded as the most important development in the treatment of breast cancer since Tamoxifen and the development of the multidisciplinary team (MDT). It is particularly exciting from an oncological polint of view as it represents success in the emerging field of specific targeted therapies to specific molecular abnormalities in tumour cells. This review will focus on the nature of the Her2 overexpression and the role of herceptin in the treatment of early breast cancer.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::063484f7d8b7892fe601e3911fe54511 Zobrazit plný text záznamu Plný text ve formátu PDF